Blacks Have Elevated HTN Risk Through Age 55 Years

Share this content:
Blacks Have Elevated HTN Risk Through Age 55 Years
Blacks Have Elevated HTN Risk Through Age 55 Years

FRIDAY, July 13, 2018 (HealthDay News) -- Blacks have considerably increased risk for hypertension than whites through age 55 years, regardless of blood pressure levels through young adulthood, according to a study published online July 11 in the Journal of the American Heart Association.

S. Justin Thomas, Ph.D., from the University of Alabama at Birmingham, and colleagues calculated the cumulative incidence of hypertension from age 18 to 55 years in the Coronary Artery Risk Development in Young Adults study. Data were included for 3,890 participants without hypertension at baseline (age 18 to 30 years).

The researchers found that in black men, black women, white men, and white women, the cumulative incidence of hypertension by age 55 years was 75.5, 75.7, 54.5, and 40.0 percent, respectively. Blacks were more likely than whites to develop hypertension, with multivariable-adjusted hazard ratios of 1.97, 1.80, and 1.59 for those with systolic blood pressure/diastolic blood pressure <110 and 70, 110 to 119/70 to 74, and 120 to 129/75 to 79 mm Hg, respectively. Among blacks and whites, parental history of hypertension and higher body mass index, serum uric acid, and systolic blood pressure/diastolic blood pressure categories correlated with increased risk, while a higher Dietary Approaches to Stop Hypertension diet adherence score correlated with lower risk.

"Regardless of blood pressure level in young adulthood, blacks have a substantially higher risk for hypertension compared with whites through 55 years of age," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »